Anti-Heat Shock Protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barré syndrome
- PMID: 20554026
- DOI: 10.1016/j.jneuroim.2010.04.024
Anti-Heat Shock Protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barré syndrome
Abstract
Myasthenia gravis (MG) is an autoimmune disorder where patients develop autoantibodies towards skeletal muscle proteins (e.g. acetylcholine receptor and muscle specific kinase), causing weakness in striated muscles. Ocular MG (OMG) represents a subtype of (MG) affecting only the periocular muscles. The pathogenesis of this phenotype remains unclear. Heat Shock Protein 70 (Hsp70) plays a role in immune regulation. Antibodies against this protein are associated with several autoimmune diseases, and its biological significance has been shown in vivo. We have therefore examined the concentration of anti-Hsp70 antibodies in sera from 35 OMG patients and 94 patients with generalized MG (GMG) using ELISA assays. The antibody concentrations were compared to those in patients with multiple sclerosis (MS), Guillain-Barré syndrome (GBS) and to healthy controls. MG patients had significantly higher anti-Hsp70 antibody concentrations than both MS patients and healthy controls. GBS patients had higher antibody levels than all other groups. No difference in antibody levels was found when comparing OMG and GMG. Our results suggest that patients with MG and GBS have a previous or current increased exposure to Hsp70 antigens. The similarity between GMG and OMG strengthens the hypothesis that OMG represents a systemic disease, similar to GMG.
Copyright 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.Clin Immunol Immunopathol. 1998 Jun;87(3):276-81. doi: 10.1006/clin.1998.4536. Clin Immunol Immunopathol. 1998. PMID: 9646837
-
Prevalence of anti-heat shock protein antibodies in cerebrospinal fluids of patients with Guillain-Barré syndrome.J Neuroimmunol. 2004 Nov;156(1-2):204-9. doi: 10.1016/j.jneuroim.2004.07.017. J Neuroimmunol. 2004. PMID: 15465612
-
Matrix metalloproteinases in myasthenia gravis.Eur Neurol. 2011;65(1):53-8. doi: 10.1159/000322737. Epub 2011 Jan 6. Eur Neurol. 2011. PMID: 21212676
-
Seronegative myasthenia gravis.Semin Neurol. 2004 Mar;24(1):125-33. doi: 10.1055/s-2004-829589. Semin Neurol. 2004. PMID: 15229799 Review.
-
[Neuroimmunological diseases: update].Nihon Rinsho. 2013 May;71(5):771-7. Nihon Rinsho. 2013. PMID: 23777080 Review. Japanese.
Cited by
-
Detection of autoantibodies to heat shock protein 70 in the saliva and urine of normal individuals.Front Immunol. 2024 Jul 29;15:1454018. doi: 10.3389/fimmu.2024.1454018. eCollection 2024. Front Immunol. 2024. PMID: 39136018 Free PMC article.
-
Myasthenia gravis presenting like guillain-barré syndrome.Case Rep Neurol. 2012 Sep;4(3):137-43. doi: 10.1159/000342448. Epub 2012 Sep 12. Case Rep Neurol. 2012. PMID: 23271998 Free PMC article.
-
Impact of Heat Shock Proteins in Neurodegeneration: Possible Therapeutical Targets.Ann Neurosci. 2022 Jan;29(1):71-82. doi: 10.1177/09727531211070528. Epub 2022 Jan 31. Ann Neurosci. 2022. PMID: 35875428 Free PMC article. Review.
-
High prevalence of Campylobacter jejuni CC21 and CC257 clonal complexes in children with gastroenteritis in Tehran, Iran.BMC Infect Dis. 2021 Jan 23;21(1):108. doi: 10.1186/s12879-021-05778-5. BMC Infect Dis. 2021. PMID: 33485317 Free PMC article.
-
Myasthenia gravis in 2025: five new things and four hopes for the future.J Neurol. 2025 Feb 22;272(3):226. doi: 10.1007/s00415-025-12922-7. J Neurol. 2025. PMID: 39987373 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical